Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Grisold, AJ; Hoenigl, M; Ovcina, I; Valentin, T; Fruhwald, S.
Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis.
J Infect Chemother. 2013; 19(6):1214-1217
Doi: 10.1007/s10156-013-0628-3
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Grisold Andrea
-
Hönigl Martin
- Co-Autor*innen der Med Uni Graz
-
Fruhwald Sonja
-
Ovcina Ismar
-
Valentin Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
We report the emergence of OXA-48 carbapenemase-producing Escherichia coli in Austria causing ventilator-associated pneumonia in a traveler returning from Egypt. Depending on resistance testing, quinolones may remain a therapeutic option for infections caused by these multiple resistant pathogens, as this class of drugs has a favorable safety and tolerability profile when compared to the alternatives. In this patient, however, the clinical course was dramatically complicated by the development of ciprofloxacin-associated rhabdomyolysis.
- Find related publications in this database (using NLM MeSH Indexing)
-
Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use
-
Ciprofloxacin - adverse effects Ciprofloxacin - therapeutic use
-
Escherichia coli - isolation & purification
-
Escherichia coli Infections - etiology Escherichia coli Infections - microbiology
-
Escherichia coli Proteins -
-
Humans -
-
Male -
-
Middle Aged -
-
Pneumonia, Ventilator-Associated - microbiology
-
Rhabdomyolysis - chemically induced Rhabdomyolysis - microbiology
-
beta-Lactamases -
- Find related publications in this database (Keywords)
-
Carbapenenem resistance
-
OXA-48
-
Austria
-
Ciprofloxacin
-
Rhabdomyolysis
-
Escherichia coli